Huapont Life Sciences Co., Ltd. (002004.SZ) SHZ

5.45

+0.5(+10.10%)

Updated at January 14 03:04PM

Currency In CNY

Valuation

Market Cap8.93B
Enterprise Value12.19B
P/E Ratio-77.27
PEG Ratio-2.14
Price/Sales Ratio0.91
Price/Book Ratio1.11
Enterprise/Revenue1.44
Enterprise/EBITDA8.98

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin-0.01
Operating Margin0.02

Management Effectiveness

Return On Assets-0
Return On Equity-0.01

Income Statement

Revenue11.66B
Revenue/Share6
Gross Profit3.84B
EBITDA2B
Net Income-298.99M
Diluted EPS-0.15

Balance Sheet

Total Cash4.03B
Total Cash/Share2.04
Total Debt9.24B
Total Debt/Equity0.95
Current Ratio1.34
Book Value Per Share8.16

Price History

52-Week Change25.87
52-Week High5.45
52-Week Low3.74
Moving Average 50 Days4.88
Moving Average 200 Days4.54

Statistics

Average Volume35.58M
Shares Outstanding1.97B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.2
Trailing Annual Dividend Yield3.67
Payout Ratio-1.48
Last Split Factor5:2
Last Split DateMay 27, 2015